Osteoarthritis (OA) is a common chronic inflammatory disease in the joints. It is one of the
leading causes of disability with increasing morbidity, which has become one of the serious …

Rheumatoid arthritis (RA) is a systemic immune disease characterized by synovial
inflammation. Patients with RA commonly experience significant damage to their hand and …

Rheumatoid arthritis (RA) and osteoarthritis (OA) are prevalent chronic health conditions.
However, despite recent advances in medical therapeutics, their treatment still represents an …

Noninfectious arthritis (NIA) comprises a class of chronic and progressive inflammatory
disorders that require early‐stage management to prevent disease progression. The most …

An efficient treatment for osteoarthritis (OA) can benefit from the local release of a high
therapeutic dose over an extended period of time. Such a treatment will minimize systemic …

Osteoarthritis (OA) involves lesions of the entire joint and remains one of the health
problems plaguing the world. The pathological mechanism of OA is complex and involves …

Nanotechnology has made significant progress in various fields, including medicine, in
recent times. The application of nanotechnology in drug delivery has sparked a lot of …

Rheumatoid arthritis (RA) is an autoimmune disease accompanies with synovial
inflammation and progressive bone destruction. Currently, anti-rheumatic drugs need high …

Osteoarthritis (OA) is a disease of the entire joint, often triggered by cartilage injury,
mediated by a cascade of inflammatory pathways involving a complex interplay among …

Drug delivery for osteoarthritis (OA) treatment is a continuous challenge because of their
poor bioavailability and rapid clearance in joints. Intra-articular (IA) drug delivery is a …